Approval · Notice of Compliance 32701 · 2024
BAQSIMI: Notice of Compliance 32701
Issued February 14, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32701
- Date
- February 14, 2024
- Company
- Amphastar Pharmaceuticals IncRancho Cucamonga, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAQSIMI | 02492415 | Marketed |
Medicinal ingredients
- GLUCAGON 3 MG per UNIT